- Anton A. BuzdinPhD, DSc, Pathway Pharmaceuticals, Wan Chai, Hong Kong, CEO; In Silico Medicine, Johns Hopkins University, USA, Vice-President; First Oncology Research and Advisory Center (Russia, Moscow), director; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry (Moscow,Interests: 84 publications, 19 grants, Editor of Frontiers in Genetics, Open Virology, Frontiers in Molecular Biosciences
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.
The biological and diagnostic role of mirna’s in hepatocellular carcinomaKurt Sartorius, Benn Sartorius, Cheryl Winkler, Anil Chuturgoon, Julia MakarovaFront. Biosci. (Landmark Ed) 2018, 23(9), 1701–1720; https://doi.org/10.2741/4668(This article belongs to the Special Issue Molecular pathways and high throughput gene expression data in cancer and age-related diseases)22Download19Citations57Views